MedGenome nets $20 mln from Sequoia
Genome research services and diagnostics provider MedGenome has raised $20 million in Series B funding. The investor was Sequoia Capital. In conjunction with the funding, Abhay Pandey of Sequoia Capital has been appointed to MedGenome's board of directors.
22 July 2015•3 mins read
